Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- RefSeek
- Hamdard University
- EBSCO A-Z
- SWB online catalog
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Advances in Pharmacoepidemiology and Drug Safety have been cited by esteemed scholars and scientists all around the world. Advances in Pharmacoepidemiology and Drug Safety has got h-index 11, which means every article in Advances in Pharmacoepidemiology and Drug Safety has got 11 average citations.
Following are the list of articles that have cited the articles published in Advances in Pharmacoepidemiology and Drug Safety.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
20 | 56 | 30 | 32 | 23 | 3 | 4 | 7 | 22 | 38 | 32 | 27 | 49 |
Research, Review articles and Editorials |
0 | 1 | 1 | 21 | 15 | 3 | 3 | 3 | 14 | 20 | 24 | 17 | 28 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 55 | 31 | 11 | 8 | 0 | 1 | 4 | 8 | 18 | 8 | 10 | 21 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 31 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
43 | 62 | 72 | 97 | 66 | 85 | 68 | 49 | 101 | 34 | 21 | 13 | 0 |
| Journal total citations count | 553 |
| Journal impact factor | 2.86 |
| Journal 5 years impact factor | 4.33 |
| Journal cite score | 5.34 |
| Journal h-index | 11 |
Important citations
Ceiro-Catasú WG, Puertas Áreas AL, Arévalo-Ortega J, Hidalgo L, Acosta-Salmón H, Rueda-Puente EO, Holguín-Peña RJ. Long-term biological effectiveness of Pochonia chlamydosporia var. catenulata against Meloidogyne incognita infection in a crop rotation systemi. International Journal of Pest Management. 2018 Oct 2;64(4):359-64.
Ramalho MD, Martins C, Morini MS, Bueno OC. What can the bacterial community of Atta sexdens (Linnaeus, 1758) tell us about the habitats in which this ant species evolves?. Insects. 2020 Jun;11(6):332.
Cooper DC, Trivedi RB, Nelson KM, Reiber GE, Eugenio EC, Beaver KA, Fan VS. Antidepressant adherence and risk of coronary artery disease hospitalizations in older and younger adults with depression. Journal of the American Geriatrics Society. 2014 Jul;62(7):1238-45.
Pradesh A. Research and Reviews: Journal of Medical and Health Sciences.
Kamarapu P. Epidemiology: Open Access. trials. 2016;45:51.
Ortega AC. Lesiones complejas en pie diabético neuroinfeccioso y su tratamiento con Heberprot-P®. Revista Cubana de Angiología y Cirugía Vascular. 2020 Dec 23;21(3).
Bhihi A, Sahibi M, Elamrani MD, Benchamkha Y. Apport du facteur de croissance épidermique humain recombinant injecté en intra-lésionnel dans le traitement des plaies chroniques. Annals of Burns and Fire Disasters. 2019 Dec 1;32(4):278-81.
Bhihi A, Sahibi M, Elamrani MD, Benchamkha Y. Apport du facteur de croissance épidermique humain recombinant injecté en intra-lésionnel dans le traitement des plaies chroniques. Annals of Burns and Fire Disasters. 2019 Dec 31;32(4):278.
Reed GA. US restrictions jeopardise health of Americans and Cubans. The Lancet. 2019 Aug 31;394(10200):733.
Reed GA. US restrictions jeopardise health of Americans and Cubans. The Lancet. 2019 Aug 31;394(10200):733.
Kamarapu P. Epidemiology: Open Access. trials. 2016;45:51.
Herrera AL. Intralesional administration of human recombinant epidermal growth factor improves healing and reduces amputations in patients with severe diabetic foot ulcers. Current therapeutic research, clinical and experimental. 2017;85:29.
Cabal-Mirabal C, Dalmau EG, Acosta JB, Zayas DD, Martínez LH, Saura PL, Nieto GG, Hernández JB, Delgado CG, González LJ. Quantitative studies of the evolution of diabetic foot lesions under EGF treatment by magnetic resonance imaging. J Radiol Res Pract. 2014;2014:783980.
Berlanga-Acosta J, Camacho-Rodríguez H, Mendoza-Marí Y, Falcón-Cama V, García-Ojalvo A, Herrera-Martínez L, Guillén-Nieto G. Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation. MEDICC review. 2020 Jul 1;22(3).
Berlanga-Acosta J, Camacho-Rodríguez H, Mendoza-Marí Y, Falcón-Cama V, García-Ojalvo A, Herrera-Martínez L, Guillén-Nieto G. Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation. MEDICC review. 2020 Jul 1;22(3).
Kamarapu P. Epidemiology: Open Access. trials. 2016;45:51.
Viswanathan V, Juttada U, Babu M. Efficacy of recombinant human epidermal growth factor (Regen-D 150) in healing diabetic foot ulcers: a hospital-based randomized controlled trial. The international journal of lower extremity wounds. 2020 Jun;19(2):158-64.
Berlanga-Acosta J, Mendoza-Mari Y, Garcia-Ojalvo A, Fernandez-Mayola M, Guillen-Nieto G. Epidermal growth factor therapy impact on scar tissue resilience of diabetic lower limbs ulcers-An enlightening hypothesis. J Diabetes Metab. 2018 Jul 31;9(7):798.
Berlanga-Acosta J, López-Saura P, Guillen-Pérez I, Guillen-Nieto G, Acevedo-Castro B, Herrera-Martínez L. Type 2 Diabetes Mellitus (T2DM): biological overview from pathways to organelles and its translation toward a torpid wound healing process. J Diabetes Metab. 2013;4(285):2.
García?Ojalvo A, Berlanga Acosta J, Figueroa?Martínez A, Béquet?Romero M, Mendoza?Marí Y, Fernández?Mayola M, Fabelo?Martínez A, Guillén?Nieto G. Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds. International wound journal. 2019 Dec;16(6):1294-303.